NextCure (NXTC) Analyst & Key Data

Analyst Consensus

Buy1 analysts

Buy

Updated Sep 12, 2026

Total Analysts1

Buy

11

Hold

1

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score4.0 / 5

Debt / Equity Score2.0 / 5

Price / Book Score4.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$7.00

Median Target+185.71%

$20.00

Potential upside vs current price

DCF Value-4.06%

$6.72

Potential downside vs current price

Current Stock Price

$7.00

Median Target+185.71%

$20.00

Potential upside vs current price

DCF Value-4.06%

$6.72

Potential downside vs current price

Analyst Consensus

Buy1 analysts

Buy

Updated Sep 12, 2026

Total Analysts1

Buy

11

Hold

1

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score4.0 / 5

Debt / Equity Score2.0 / 5

Price / Book Score4.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$7.00

Median Target+185.71%

$20.00

Potential upside vs current price

DCF Value-4.06%

$6.72

Potential downside vs current price

Current Stock Price

$7.00

Median Target+185.71%

$20.00

Potential upside vs current price

DCF Value-4.06%

$6.72

Potential downside vs current price

NextCure, Inc.